September 2024 OIG Work Plan Updates [eBrief]

The OIG released new Work Plan items for September 2024 and we’re covering three key areas that could impact your compliance strategy.

Here’s a sneak peek at our eBrief:

FDA Drug Safety Signals: The OIG will review how the FDA is responding to potential risks with drugs already on the market.
Medicaid MLRs & Remittance: The OIG is checking if Medicaid managed care plans are meeting their Medical Loss Ratio requirements and properly reporting remittances.
Hospital Price Transparency: Hospitals are still under the microscope for compliance with price transparency rules.

Now’s a great time to review your compliance practices in these areas.